| European Case Law Identifier: | ECLI:EP:BA:2000:T074397.20000726 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 26 July 2000 | ||||||||
| Case number: | T 0743/97 | ||||||||
| Application number: | 87902884.3 | ||||||||
| IPC class: | C12N 15/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Novel thrombolytic proteins | ||||||||
| Applicant name: | GENETICS INSTITUTE, INC. | ||||||||
| Opponent name: | Boehringer Ingelheim GmbH | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - added subject-matter (no) Clarity (yes) Sufficiency of disclosure (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970743eu1.html
Date retrieved: 17 May 2021